Manufacturing

Articles

The companies have been awarded a collaborative grant of £1.9 million (US$2.6 million) from Innovate UK.

Cobra Biologics, Symbiosis Awarded Innovate UK Grant

Amgen plans to invest approximately $300 million in a new biomanufacturing plant in the United States.

Amgen to Invest $300 Million in New Biomanufacturing Facility

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

Layout and supply details must be considered when implementing a fully disposable biopharmaceutical manufacturing process.

Designing a Single-Use Biopharmaceutical Process

Sade Mokuolu, PhD, is group product compliance manager, Watson-Marlow Fluid Technology Group. 

Proposed guidance documents assist drug manufacturers in qualifying single-use systems for commercial drug production.

New Standards Define Single-Use Materials Qualification

A collaboration between The Centre for Process Innovation and The Roslin Institute aims to develop commercially viable and scalable methods of producing biologics using transgenic animals.

CPI and The Roslin Institute Collaborate on New Methods to Manufacture Biologics

Rita Peters is the former editorial director of 

Pharmaceutical Technology, Pharmaceutical Technology Europe

A different perspective on controlling fixed costs of biomanufacturing, based on know-how from other industries, provides a competitive edge, says the CEO of Samsung BioLogics. 

Bigger is Better in Samsung's Approach to Biomanufacturing

The company will invest $139 million in sterile manufacturing technology at its facility in Ballytivnan, Sligo, Ireland to support the growth of its oncology pipeline.

AbbVie Expands Oncology Capability at Ireland Site

The funding from the Walloon Region will enable Univercells to start developing a manufacturing platform aimed at driving down costs of biosimilars manufacturing.

Univercells to Develop Antibody Production Platform with $2.9-Million Grant

Lonza Pharma & Biotech's's Modular Automated Sampling Technology (MAST) platform, which allows for the collection of up to 10 sterile sample sources for automated analysis in multiple analytical devices, won the CPhI Pharma Award 2017 for Excellence in Pharma: Bioprocessing.

Modular Automated Technology Allows Multiple Bioreactor Sterile Sampling

GE Healthcare will equip Cellular Biomedicine Group's cell therapy manufacturing facility in Shanghai, China, with its FlexFactory single-use platform, designed to speed up cell therapy manufacturing timelines.

Manufacturing, Biologic Drugs